The hemoglobin testing market size has grown strongly in recent years. It will grow from $2.79 billion in 2025 to $3.03 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to expansion of routine blood testing practices, growth in anemia screening programs, increasing hospital diagnostic workloads, availability of cost-effective testing kits, rising public health initiatives.
The hemoglobin testing market size is expected to see strong growth in the next few years. It will grow to $4.28 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to increasing demand for decentralized diagnostics, rising adoption of home testing devices, expansion of digital health monitoring, growing focus on early disease detection, continuous innovation in diagnostic accuracy. Major trends in the forecast period include increasing adoption of point-of-care hemoglobin testing, rising use of portable hemoglobin analyzers, growing demand for rapid blood screening, expansion of home-based diagnostic testing, enhanced focus on preventive health screening.
The hemoglobin testing market is poised for growth, driven by the increasing prevalence of chronic disorders such as diabetes. Diabetes, a chronic condition characterized by insufficient insulin production or utilization, necessitates regular monitoring through Hemoglobin A1c tests (HbA1c). These tests, recommended by the American Diabetes Association, play a crucial role in diabetes diagnosis. With over 34 million Americans having diabetes and an additional 88 million at risk, the demand for HbA1c testing devices is set to rise. Furthermore, global projections indicate a substantial increase in diabetes cases, reaching 783,700 individuals by 2045, emphasizing the pivotal role of hemoglobin A1c testing devices in managing chronic disorders.
Leading companies in the hemoglobin testing market are creating innovative fingerstick blood test solutions to enable patients to conveniently monitor their hemoglobin levels at home, support early detection of anemia, and enhance overall health management. These advanced fingerstick blood test methods allow for quick and easy blood sample collection through a simple finger prick, making diagnostic testing more efficient and less invasive. For example, in February 2024, Sanguina Inc., a health technology company based in the U.S., launched AnemoCheck Home, the first FDA-cleared home hemoglobin test kit. AnemoCheck Home is designed to provide users with accurate hemoglobin readings using a simple finger prick. This user-friendly kit includes all the necessary components, such as a testing device and clear instructions, enabling individuals to conduct the test without needing a laboratory visit. AnemoCheck Home not only allows patients to regularly monitor their hemoglobin levels but also promotes early detection of potential health issues like anemia.
In July 2024, F. Hoffmann-La Roche Ltd., a Switzerland-based biotechnology and diagnostics leader, acquired LumiraDx for an undisclosed amount. Through this acquisition, Roche aims to expand its decentralized testing capabilities and improve global access to primary care diagnostics, particularly in low- and middle-income regions. LumiraDx Ltd., based in the UK, specializes in hemoglobin testing, including its HbA1c assay.
Major companies operating in the hemoglobin testing market are Abbott Laboratories Inc, F Hoffmann La Roche Ltd, Danaher Corporation, Thermo Fisher Scientific Inc, Bio Rad Laboratories Inc, Sysmex Corporation, Siemens Healthineers AG, Mindray Medical International Limited, Nihon Kohden Corporation, EKF Diagnostics Holdings plc, ARKRAY Inc, Nova Biomedical Corporation, Beckman Coulter Inc, Radiometer A S, DiaSys Diagnostic Systems GmbH, Erba Diagnostics Inc, Tosoh Corporation, ACON Laboratories Inc, Diazyme Laboratories Inc, Humasis Co Ltd, BioMedomics Inc, NanoEntek Inc.
Asia-Pacific was the largest regions in the hemoglobin testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global hemoglobin testing market report during the forecast period. The regions covered in the hemoglobin testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hemoglobin testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the hemoglobin testing market by increasing costs of imported diagnostic reagents, analyzers, sensors, and electronic components used in laboratory and point-of-care testing devices. Hospitals and diagnostic laboratories in North America and Europe are most affected due to reliance on imported testing equipment, while Asia-Pacific faces cost pressure on manufacturing consumables for export. These tariffs are increasing testing costs and procurement expenses. However, they are also encouraging local production of diagnostic kits, regional assembly of analyzers, and innovation in cost-efficient testing solutions.
The hemoglobin testing market research report is one of a series of new reports that provides hemoglobin testing market statistics, including hemoglobin testing industry global market size, regional shares, competitors with a hemoglobin testing market share, detailed hemoglobin testing market segments, market trends and opportunities, and any further data you may need to thrive in the hemoglobin testing industry. This hemoglobin testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Hemoglobin testing is a medical procedure designed to measure the concentration of hemoglobin in the blood. Hemoglobin, a protein found in red blood cells, plays a crucial role in transporting oxygen from the lungs to the tissues and organs of the body.
The primary types of products in hemoglobin testing include reagents and consumables, as well as equipment. The reagents and consumables segment in the hemoglobin testing market encompasses various chemical reagents and consumable products utilized in the process of hemoglobin testing. Various technologies are employed for hemoglobin testing, including chromatography, immunoassay, spectrophotometry, and others. These testing products find application in diverse settings such as hospitals, clinics, laboratories, home care settings, blood banks, and others.
The hemoglobin testing market consists of revenues earned by entities by providing services such as hemoglobin-cyanide, vanzetti's azide methemoglobin, reagent-less, non-invasive methods, and hemoglobin electrophoresis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The hemoglobin testing market size is expected to see strong growth in the next few years. It will grow to $4.28 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to increasing demand for decentralized diagnostics, rising adoption of home testing devices, expansion of digital health monitoring, growing focus on early disease detection, continuous innovation in diagnostic accuracy. Major trends in the forecast period include increasing adoption of point-of-care hemoglobin testing, rising use of portable hemoglobin analyzers, growing demand for rapid blood screening, expansion of home-based diagnostic testing, enhanced focus on preventive health screening.
The hemoglobin testing market is poised for growth, driven by the increasing prevalence of chronic disorders such as diabetes. Diabetes, a chronic condition characterized by insufficient insulin production or utilization, necessitates regular monitoring through Hemoglobin A1c tests (HbA1c). These tests, recommended by the American Diabetes Association, play a crucial role in diabetes diagnosis. With over 34 million Americans having diabetes and an additional 88 million at risk, the demand for HbA1c testing devices is set to rise. Furthermore, global projections indicate a substantial increase in diabetes cases, reaching 783,700 individuals by 2045, emphasizing the pivotal role of hemoglobin A1c testing devices in managing chronic disorders.
Leading companies in the hemoglobin testing market are creating innovative fingerstick blood test solutions to enable patients to conveniently monitor their hemoglobin levels at home, support early detection of anemia, and enhance overall health management. These advanced fingerstick blood test methods allow for quick and easy blood sample collection through a simple finger prick, making diagnostic testing more efficient and less invasive. For example, in February 2024, Sanguina Inc., a health technology company based in the U.S., launched AnemoCheck Home, the first FDA-cleared home hemoglobin test kit. AnemoCheck Home is designed to provide users with accurate hemoglobin readings using a simple finger prick. This user-friendly kit includes all the necessary components, such as a testing device and clear instructions, enabling individuals to conduct the test without needing a laboratory visit. AnemoCheck Home not only allows patients to regularly monitor their hemoglobin levels but also promotes early detection of potential health issues like anemia.
In July 2024, F. Hoffmann-La Roche Ltd., a Switzerland-based biotechnology and diagnostics leader, acquired LumiraDx for an undisclosed amount. Through this acquisition, Roche aims to expand its decentralized testing capabilities and improve global access to primary care diagnostics, particularly in low- and middle-income regions. LumiraDx Ltd., based in the UK, specializes in hemoglobin testing, including its HbA1c assay.
Major companies operating in the hemoglobin testing market are Abbott Laboratories Inc, F Hoffmann La Roche Ltd, Danaher Corporation, Thermo Fisher Scientific Inc, Bio Rad Laboratories Inc, Sysmex Corporation, Siemens Healthineers AG, Mindray Medical International Limited, Nihon Kohden Corporation, EKF Diagnostics Holdings plc, ARKRAY Inc, Nova Biomedical Corporation, Beckman Coulter Inc, Radiometer A S, DiaSys Diagnostic Systems GmbH, Erba Diagnostics Inc, Tosoh Corporation, ACON Laboratories Inc, Diazyme Laboratories Inc, Humasis Co Ltd, BioMedomics Inc, NanoEntek Inc.
Asia-Pacific was the largest regions in the hemoglobin testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global hemoglobin testing market report during the forecast period. The regions covered in the hemoglobin testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hemoglobin testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the hemoglobin testing market by increasing costs of imported diagnostic reagents, analyzers, sensors, and electronic components used in laboratory and point-of-care testing devices. Hospitals and diagnostic laboratories in North America and Europe are most affected due to reliance on imported testing equipment, while Asia-Pacific faces cost pressure on manufacturing consumables for export. These tariffs are increasing testing costs and procurement expenses. However, they are also encouraging local production of diagnostic kits, regional assembly of analyzers, and innovation in cost-efficient testing solutions.
The hemoglobin testing market research report is one of a series of new reports that provides hemoglobin testing market statistics, including hemoglobin testing industry global market size, regional shares, competitors with a hemoglobin testing market share, detailed hemoglobin testing market segments, market trends and opportunities, and any further data you may need to thrive in the hemoglobin testing industry. This hemoglobin testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Hemoglobin testing is a medical procedure designed to measure the concentration of hemoglobin in the blood. Hemoglobin, a protein found in red blood cells, plays a crucial role in transporting oxygen from the lungs to the tissues and organs of the body.
The primary types of products in hemoglobin testing include reagents and consumables, as well as equipment. The reagents and consumables segment in the hemoglobin testing market encompasses various chemical reagents and consumable products utilized in the process of hemoglobin testing. Various technologies are employed for hemoglobin testing, including chromatography, immunoassay, spectrophotometry, and others. These testing products find application in diverse settings such as hospitals, clinics, laboratories, home care settings, blood banks, and others.
The hemoglobin testing market consists of revenues earned by entities by providing services such as hemoglobin-cyanide, vanzetti's azide methemoglobin, reagent-less, non-invasive methods, and hemoglobin electrophoresis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Hemoglobin Testing Market Characteristics
3. Hemoglobin Testing Market Supply Chain Analysis
4. Global Hemoglobin Testing Market Trends and Strategies
5. Hemoglobin Testing Market Analysis of End Use Industries
7. Global Hemoglobin Testing Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Hemoglobin Testing Total Addressable Market (TAM) Analysis for the Market
9. Hemoglobin Testing Market Segmentation
10. Hemoglobin Testing Market Regional and Country Analysis
11. Asia-Pacific Hemoglobin Testing Market
12. China Hemoglobin Testing Market
13. India Hemoglobin Testing Market
14. Japan Hemoglobin Testing Market
15. Australia Hemoglobin Testing Market
16. Indonesia Hemoglobin Testing Market
17. South Korea Hemoglobin Testing Market
18. Taiwan Hemoglobin Testing Market
19. South East Asia Hemoglobin Testing Market
20. Western Europe Hemoglobin Testing Market
21. UK Hemoglobin Testing Market
22. Germany Hemoglobin Testing Market
23. France Hemoglobin Testing Market
24. Italy Hemoglobin Testing Market
25. Spain Hemoglobin Testing Market
26. Eastern Europe Hemoglobin Testing Market
27. Russia Hemoglobin Testing Market
28. North America Hemoglobin Testing Market
29. USA Hemoglobin Testing Market
30. Canada Hemoglobin Testing Market
31. South America Hemoglobin Testing Market
32. Brazil Hemoglobin Testing Market
33. Middle East Hemoglobin Testing Market
34. Africa Hemoglobin Testing Market
36. Hemoglobin Testing Market Competitive Landscape and Company Profiles
37. Hemoglobin Testing Market Other Major and Innovative Companies
40. Hemoglobin Testing Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Hemoglobin Testing Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses hemoglobin testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for hemoglobin testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemoglobin testing market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Reagents And Consumables; Equipment2) By Technology: Spectrophotometry; Chromatography; Biosensor-Based; Electrochemical-Based
3) By End User: Hospitals; Clinics; Laboratories; Home Care Settings; Blood Banks; Other End Users
Subsegments:
1) By Reagents And Consumables: Hemoglobin Testing Kits; Control Solutions; Test Strips; Quality Control Products2) By Equipment: Hemoglobin Meters; Analyzers; Point-Of-Care Devices
Companies Mentioned: Abbott Laboratories Inc; F Hoffmann La Roche Ltd; Danaher Corporation; Thermo Fisher Scientific Inc; Bio Rad Laboratories Inc; Sysmex Corporation; Siemens Healthineers AG; Mindray Medical International Limited; Nihon Kohden Corporation; EKF Diagnostics Holdings plc; ARKRAY Inc; Nova Biomedical Corporation; Beckman Coulter Inc; Radiometer A S; DiaSys Diagnostic Systems GmbH; Erba Diagnostics Inc; Tosoh Corporation; ACON Laboratories Inc; Diazyme Laboratories Inc; Humasis Co Ltd; BioMedomics Inc; NanoEntek Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Hemoglobin Testing market report include:- Abbott Laboratories Inc
- F Hoffmann La Roche Ltd
- Danaher Corporation
- Thermo Fisher Scientific Inc
- Bio Rad Laboratories Inc
- Sysmex Corporation
- Siemens Healthineers AG
- Mindray Medical International Limited
- Nihon Kohden Corporation
- EKF Diagnostics Holdings plc
- ARKRAY Inc
- Nova Biomedical Corporation
- Beckman Coulter Inc
- Radiometer A S
- DiaSys Diagnostic Systems GmbH
- Erba Diagnostics Inc
- Tosoh Corporation
- ACON Laboratories Inc
- Diazyme Laboratories Inc
- Humasis Co Ltd
- BioMedomics Inc
- NanoEntek Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.03 Billion |
| Forecasted Market Value ( USD | $ 4.28 Billion |
| Compound Annual Growth Rate | 9.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
